Umecrine AB

Umecrine was founded in 2000 by leading scientists at Umeå University. We are active in research and development of pharmaceutical agents to reduce negative mental and physical CNS-related conditions caused by endogenous sex and stress hormones on the brain. This is a unique and novel treatment principle based on antagonizing the action of GABA-A (GABA-A modulating steroid antagonists, GAMSA) receptor modulating steroids.


Contact: Torbjörn Bäckström, CEO

Contact details
UNC, Norrlands University Hospital, SE-90185 Umeå, Sweden
Phone: +4672 - 203 13 13